Insider · CIK 0001387652
Robert McNamara
Files at AXNX (Axonics, Inc.), RCEL (AVITA Medical, Inc.). First filing Feb 20, 2025, latest Mar 10, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCEL: AVITA Medical, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | AVITA Medical, Inc. | $91k 11,000 shares | +24% | 0% from low-41% from high | |
| 43Moderate | AVITA Medical, Inc. | $101k 10,000 shares | +28% | +17% from low-29% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +10,022 | - | - | 66,771 | Jun 5, 2025 |
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +4,295 | $0.00 | $0 | 4,295 | Jun 5, 2025 |
| Mar 6, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +11,000 | $8.30 | $91k | 56,749 | Mar 10, 2025 |
| Feb 20, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +10,000 | $10.09 | $101k | 45,749 | Feb 20, 2025 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Common Stock | -14,861 | $71.00 | $1.1M | 0 | Nov 15, 2024 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | $36.90 | $369k | 0 | Nov 15, 2024 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,333 | $33.85 | $113k | 0 | Nov 15, 2024 |
| Nov 15, 2024 | AXNX Axonics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | $56.20 | $281k | 0 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.